5 Mounjaro received MHRA approval for weight management in November 2023, with NICE TA1026 following in December 2024
Decapeptyl: EUR 536M Key Peptide Products: Lanreotide (Somatuline somatostatin analogue for NETs, acromegaly), triptorelin (Decapeptyl GnRH agonist for prostate/breast cancer, endometriosis), abarelix (predecessor), cabozantinib (Cabometyx kinase inhibitor) Therapeutic Segments: Oncology (NETs, prostate cancer, breast cancer)
But the ride of our lives
This is why peptides for healing have become a major topic in sports medicine and regenerative medicine research, particularly among athletes, weekend warriors, and clinicians managing stubborn soft-tissue injuries
Ginsenoside F2 restrains hepatic steatosis and inflammation by altering the binding affinity of liver X receptor coregulators